NO952138D0 - Cefiximpreparat - Google Patents

Cefiximpreparat

Info

Publication number
NO952138D0
NO952138D0 NO952138A NO952138A NO952138D0 NO 952138 D0 NO952138 D0 NO 952138D0 NO 952138 A NO952138 A NO 952138A NO 952138 A NO952138 A NO 952138A NO 952138 D0 NO952138 D0 NO 952138D0
Authority
NO
Norway
Prior art keywords
micron
max
particles
suspensions
diameter
Prior art date
Application number
NO952138A
Other languages
English (en)
Other versions
NO952138L (no
Inventor
Joachim Bolz
Gertraud Wagner
Eckhard Oelrich
Dirk Radtke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO952138D0 publication Critical patent/NO952138D0/no
Publication of NO952138L publication Critical patent/NO952138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
NO952138A 1994-05-31 1995-05-30 Cefiximpreparat NO952138L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418957A DE4418957A1 (de) 1994-05-31 1994-05-31 Cefixim-Zubereitung

Publications (2)

Publication Number Publication Date
NO952138D0 true NO952138D0 (no) 1995-05-30
NO952138L NO952138L (no) 1995-12-01

Family

ID=6519407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952138A NO952138L (no) 1994-05-31 1995-05-30 Cefiximpreparat

Country Status (25)

Country Link
US (1) US5776926A (no)
EP (1) EP0685232B1 (no)
JP (1) JPH07330607A (no)
KR (1) KR950031077A (no)
CN (1) CN1117383A (no)
AT (1) ATE190844T1 (no)
AU (1) AU694201B2 (no)
CA (1) CA2150442A1 (no)
CO (1) CO4410174A1 (no)
CZ (1) CZ138595A3 (no)
DE (2) DE4418957A1 (no)
DK (1) DK0685232T3 (no)
ES (1) ES2146265T3 (no)
FI (1) FI952629A (no)
GR (1) GR3033704T3 (no)
HU (1) HU218217B (no)
IL (1) IL113917A0 (no)
NO (1) NO952138L (no)
NZ (1) NZ272216A (no)
PE (1) PE18796A1 (no)
PL (1) PL308838A1 (no)
PT (1) PT685232E (no)
SK (1) SK72795A3 (no)
TW (1) TW301610B (no)
ZA (1) ZA954427B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712332T2 (de) * 1996-02-29 2002-10-02 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
BRPI0418769A (pt) * 2004-05-10 2007-10-09 Lupin Ltd composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima
US9233112B2 (en) 2006-04-13 2016-01-12 Lupin Limited Pharmaceutical compositions of cefixime
WO2007119249A2 (en) * 2006-04-13 2007-10-25 Lupin Limited Pharmaceutical compositions of cefixime
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
CN105377236B (zh) * 2013-07-18 2019-04-23 桑多斯股份公司 用于抗生素干糖浆制剂的粉末混合物
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins

Also Published As

Publication number Publication date
ZA954427B (en) 1996-01-24
CO4410174A1 (es) 1997-01-09
CA2150442A1 (en) 1995-12-01
AU2033595A (en) 1995-12-07
CN1117383A (zh) 1996-02-28
PE18796A1 (es) 1996-06-04
DE4418957A1 (de) 1995-12-07
HU9501570D0 (en) 1995-07-28
HU218217B (hu) 2000-06-28
TW301610B (no) 1997-04-01
CZ138595A3 (en) 1996-04-17
DK0685232T3 (da) 2000-08-21
NO952138L (no) 1995-12-01
EP0685232A3 (de) 1996-05-08
DE59508024D1 (de) 2000-04-27
NZ272216A (en) 1996-05-28
EP0685232A2 (de) 1995-12-06
ATE190844T1 (de) 2000-04-15
PT685232E (pt) 2000-08-31
ES2146265T3 (es) 2000-08-01
AU694201B2 (en) 1998-07-16
EP0685232B1 (de) 2000-03-22
SK72795A3 (en) 1996-01-10
GR3033704T3 (en) 2000-10-31
US5776926A (en) 1998-07-07
JPH07330607A (ja) 1995-12-19
FI952629A0 (fi) 1995-05-30
KR950031077A (ko) 1995-12-18
HUT74421A (en) 1996-12-30
FI952629A (fi) 1995-12-01
IL113917A0 (en) 1995-08-31
PL308838A1 (en) 1995-12-11

Similar Documents

Publication Publication Date Title
IT1267391B1 (it) Procedimento per l'assemblaggio di una batteria bipolare piombo-acido e batteria bipolare ottenuta con tale procedimento.
HK1089387A1 (en) Estrogenic compounds as antimitotic agents
TW349849B (en) Xanthan gelling agents
FI952629A0 (fi) Kefiksiimivalmiste
USD279495S (en) Dumbbell
USD304057S (en) Exercise rod
IL99501A0 (en) Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
USD266142S (en) Suspension arm for supporting a load such as a wire or cable
USD290729S (en) Inflatable club
DE3875199T2 (de) Dispergiermittel und dieses enthaltende feststoffsuspension.
USD280401S (en) Terminal pin
DE3863687D1 (de) Tinten-zusammensetzungen und deren zubereitung.
AU6764890A (en) 1,3-disubstituted 5-azolyloxy-phenylcarbomyl-4, 6-pyrimidinedione derivatives and the hydrogenated analogues thereof
ATE70562T1 (de) Agrochemische verbindung, genannt no. 51262, deren herstellung und benutzung.
USD323837S (en) Ball separator for bearing assembly
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.
FI945645A (fi) Flegmatisoitu räjähdysaine
ZA88655B (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
USD282495S (en) Bellows unit for aspirator or resuscitator for newborn animals
DE69820098D1 (de) Diamantpartikel, bestehend aus einem diamantenem kern und einem diamantenem überzug
AU3322589A (en) Lubricant
AU3856595A (en) Hydrate for drug use
RU96115480A (ru) Лекарственное средство, обладающее холелитолитическим действием
AU9541898A (en) Azines containing the 5,6-di-hydro-(1,4,2) dioxazine-3-yl group and the use thereof as fungicides
FR2575070B3 (fr) Composition a effet assainissant, en particulier pour le parfumage d'air ambiant